TABLE 1.
SNP | CHR | Pos | beta.exposure | se.exposure | pval.exposure | beta.outcome | se.outcome | pval.outcome |
rs17020127 | 1 | 107,815,461 | –0.2289 | 0.0306 | 7.95E-14 | –0.2438 | 0.1347 | 0.070361 |
rs181871363 | 1 | 113,318,163 | –0.276 | 0.0456 | 1.37E-09 | –0.2917 | 0.2025 | 0.1499 |
rs11571293 | 2 | 203,852,990 | 0.1259 | 0.0215 | 5.11E-09 | 0.0757 | 0.0928 | 0.4147 |
rs9860547 | 3 | 188,411,191 | –0.1121 | 0.0205 | 4.26E-08 | –0.0386 | 0.0888 | 0.663599 |
rs1993945 | 5 | 77,222,370 | 0.1468 | 0.0201 | 2.72E-13 | 0.0558 | 0.0876 | 0.5244 |
rs9272245 | 6 | 32,635,095 | 0.1458 | 0.025 | 5.75E-09 | 0.2047 | 0.0927 | 0.7014 |
rs9273400 | 6 | 32,659,351 | –0.2252 | 0.022 | 1.41E-24 | –0.1314 | 0.095 | 0.1667 |
rs925489 | 9 | 97,784,318 | –0.1887 | 0.0211 | 3.31E-19 | –0.0102 | 0.0904 | 0.9098 |
rs229536 | 22 | 37,193,829 | –0.1172 | 0.0202 | 6.70E-09 | 0.0347 | 0.0879 | 0.6933 |
NAFLD, non-alcoholic fatty liver disease; SNP, single-nucleotide polymorphism.